The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the ...
In August, the agency announced a new program called FDA PreCheck, 2 which is designed to increase regulatory predictability ...
The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, ...
Hosted on MSN
Lantheus Holdings, Inc. (LNTH) Announces FDA Approval of its New Drug Application for F 18 PSMA Imaging Agent
With a price-to-earnings multiple under 15x and its relative strength index below 40, Lantheus Holdings, Inc. (NASDAQ:LNTH) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now.
While a new facility setup program aimed at encouraging onshoring received a positive reception at a recent meeting, industry ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from Shanghai Henlius Biotech, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback